U.S. Stock News

AbbVie (ABBV) is back in focus after releasing nine year final results from its Phase 3 CLL14 trial, where a fixed duration venetoclax plus obinutuzumab regimen improved progression free survival in untreated CLL patients. See our latest analysis for AbbVie. The latest CLL14 update lands after a mixed few sessions for AbbVie, with the share price slipping 2.7% on the day to $221.59, while still showing a 5.3% 30 day share price return and a 19.9% one year total shareholder return that points...

With inflation, interest rate shifts and energy headlines all pulling markets in different directions, many investors are looking for steadier income rather than chasing the latest story stock. That is where Dividend Powerhouses with yields above 5% can help, focusing on companies whose payouts are covered, growing and relatively stable. This article walks through three of the strongest dividend stocks from that screener, explaining how they might fit into a portfolio that aims to balance...

Earlier this quarter, Dropbox reported quarterly results with revenue roughly flat year on year but slightly above analyst expectations, alongside solid EBITDA and billings outperformance. The addition of 10,000 customers to reach 18.09 million suggests Dropbox is still finding ways to grow its user base despite revenue headwinds. With Dropbox outperforming revenue and EBITDA expectations, we'll now examine how this stronger-than-expected quarter affects its longer-term investment...

Cipher Digital (CIFR) is back in focus after the company completed a private placement of senior secured notes to finance its Stingray high performance computing data center, backed by a 15 year lease to Amazon Web Services. See our latest analysis for Cipher Digital. The recent private placement and long term Amazon Web Services lease come against a backdrop of strong momentum for Cipher Digital, with a 30 day share price return of 28.04% and a year to date share price return of 60.68%,...

If you are wondering whether Corteva stock still offers value at around US$75.71 per share, the key question is how its current price compares with its underlying fundamentals. The share price has eased slightly over the past week and is down about 7.9% over the last month, yet it remains up 11.7% year to date and 3.0% over the past year, with a 36.7% return over three years and 84.1% over five years. Recent coverage around Corteva has focused on its position within the broader chemicals...

Hut 8 Corp. recently appointed former Merrill Lynch CEO E. Stanley O’Neal as Chair of the Board and filed a US$528.40 million shelf registration for 5,000,000 common shares tied to an employee stock ownership plan, supporting its shift from bitcoin mining toward long-term AI and data center infrastructure. These governance and financing moves reinforce Hut 8’s effort to reposition itself as an energy and compute infrastructure platform backed by long-duration AI data center contracts and...

In recent days, EchoStar completed multi-billion-dollar spectrum sale agreements with SpaceX and AT&T, receiving a mix of cash, SpaceX stock, and interest-payment support while also confronting liquidity concerns after its DISH DBS unit skipped an interest payment and entered a grace-period default. These moves have effectively tied EchoStar’s fortunes more closely to SpaceX’s newly public valuation and the execution of large spectrum transactions, while options trading and sector capital...

Earlier in June 2026, Xylem Inc. announced a long-term agreement to design, build and operate advanced water treatment and reuse systems for Dow’s large industrial complex in Fort Saskatchewan, Alberta, while Dow began notifying employees of approximately 4,500 layoffs under its Transform to Outperform cost program. Together, the workforce reductions and the Alberta water reuse project highlight how Dow is reshaping both its cost base and its approach to resource efficiency and environmental...

Recent pressure on General Mills (GIS) dividends, after earnings fell short of covering payments, has put the stock under close watch as management also moves to reset its underperforming Blue Buffalo Wilderness pet food line. See our latest analysis for General Mills. At a share price of $34.27, General Mills has seen a modest 7 day share price return of 3.41% and a 30 day share price return of 3.88%. However, momentum still looks weak given the 90 day share price decline of 11.54% and a 1...

Anyone interested in World Acceptance Corporation ( NASDAQ:WRLD ) should probably be aware that the Senior VP, Luke...

A 2X leveraged ETF like SPCU aims to double the daily move of the SpaceX trade. But there is more than meets the eye in how that works, and the details are worth knowing.

Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...

Helen of Troy Limited ( NASDAQ:HELE ), might not be a large cap stock, but it received a lot of attention from a...

Earlier in 2026, Revolution Medicines reported Phase 3 data showing its RAS(ON) inhibitor daraxonrasib delivered a statistically significant survival benefit in advanced pancreatic cancer, supporting an ongoing New Drug Application process and expanded access program in the US. Beyond this single trial, the readout effectively confirms RAS(ON) inhibition as a clinically validated approach in a high‑mortality tumor, with implications for the company’s broader RAS-focused pipeline and its...

Ligand Pharmaceuticals (LGND) has drawn fresh attention after recent trading, with the stock last closing at US$253.25. For investors, the focus now is on how this biopharmaceutical licensing model aligns with their portfolio goals. See our latest analysis for Ligand Pharmaceuticals. The recent 1 day share price decline of 0.90% to US$253.25 comes after a strong run, with a 30 day share price return of 18.78% and a 1 year total shareholder return of 120.20%, suggesting momentum has been...

If you are wondering whether Datadog stock is offering value at current levels, it helps to separate the recent share price excitement from what the fundamentals might support. Datadog last closed at US$233.09, with returns of 0.6% over 7 days, 12.1% over 30 days, 74.2% year to date, 91.2% over 1 year, 143.4% over 3 years and 127.7% over 5 years. These figures naturally raise questions about what is already reflected in the price. Recent coverage around Datadog has focused on its role in...

Earlier in June 2026, Viasat announced it had been awarded a prime contract by the U.S. Space Force to build, launch and operate the first small, maneuverable geosynchronous satellite under the Protected Tactical SATCOM‑Global program, including ground systems and five years of operations support. This Swarm 1 Delivery Order advances Viasat’s role in secure, anti‑jam military communications and could deepen its position as a key supplier of resilient GEO satellite infrastructure to the U.S...

Muted stock reaction to new battery order Enovix (ENVX) recently announced a new battery order, but the stock reaction has been muted as investors weigh ongoing concerns about sustained demand and slow progress in drone battery applications over recent quarters. See our latest analysis for Enovix. Against this muted reaction to the new order, Enovix’s recent share price performance has been mixed, with a 46.28% 90 day share price return but a year to date share price decline of 10.27% and a 1...

Earlier this week, the Trump administration announced a peace deal enabling the reopening of the Strait of Hormuz, which pushed long-term Treasury yields lower and improved the backdrop for rate‑sensitive assets such as high-growth software companies. This shift in bond markets matters for MongoDB because lower discount rates can increase the present value investors assign to its expected future cash flows, especially given its growth-focused business model. We’ll now examine how the drop in...

Humana (HUM) has drawn fresh attention after recent trading, with the stock showing a mix of short term gains and longer term declines that raises questions about how investors currently view its valuation. See our latest analysis for Humana. Recent trading has pushed Humana’s share price to $380.26, with a 30 day share price return of 24.63% and a 1 year total shareholder return of 64.10%. However, 3 and 5 year total shareholder returns remain in decline, suggesting momentum has recently...

Recent analysis of StoneX Group highlights strong past revenue and earnings per share growth, underlining the company’s expanding presence across its global financial services network. Commentary also points to balance sheet strength and rising tangible book value per share, reinforcing confidence in the durability of StoneX’s business model. We’ll now examine how this emphasis on earnings and tangible book value growth shapes StoneX Group’s broader investment narrative. We've uncovered the...

First Industrial Realty Trust (FR) drew fresh attention after reporting quarterly earnings and revenue that exceeded expectations, supported by healthy leasing activity, rental growth, and demand for its logistics and warehouse focused industrial portfolio. See our latest analysis for First Industrial Realty Trust. Against this earnings backdrop, First Industrial Realty Trust’s share price has moved steadily higher, with a year to date share price return of 9.45% and a 1 year total...

Earlier in June 2026, REX American Resources filed a US$69.00 million shelf registration for 1,500,000 common shares tied to an ESOP-related offering, while also reporting record Q1 2026 earnings per share of US$0.56 that exceeded expectations despite softer revenue. The board’s approval of a new Restricted Stock Unit Award Agreement under the 2026 Incentive Plan highlights an increased focus on equity-based compensation to align employees with long-term corporate objectives. Next, we’ll...

Microsoft is facing a proposed shareholder class action lawsuit alleging it misled investors about AI and Azure growth and Copilot adoption. At the same time, Microsoft is resetting its Xbox business, with a hardware component crunch and planned layoffs affecting the division. The combination of securities litigation and internal restructuring is raising questions about Microsoft’s AI execution and its consumer gaming business. For investors tracking Microsoft, ticker NasdaqGS:MSFT, these...